APA

Sacco M. G., Ungari M., Catò E. M., Villa A., Strina D., Notarangelo L. D., Jonkers J., Zecca L., Facchetti F. & Vezzoni P. (20010215). Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome. : Cancer gene therapy.

Chicago

Sacco M G, Ungari M, Catò E M, Villa A, Strina D, Notarangelo L D, Jonkers J, Zecca L, Facchetti F and Vezzoni P. 20010215. Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome. : Cancer gene therapy.

Harvard

Sacco M. G., Ungari M., Catò E. M., Villa A., Strina D., Notarangelo L. D., Jonkers J., Zecca L., Facchetti F. and Vezzoni P. (20010215). Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome. : Cancer gene therapy.

MLA

Sacco M G, Ungari M, Catò E M, Villa A, Strina D, Notarangelo L D, Jonkers J, Zecca L, Facchetti F and Vezzoni P. Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome. : Cancer gene therapy. 20010215.